ArticleMicrobial physiology2026
Investigating the Trans Effects of IS<italic>1</italic> Transposases on Intragenomic DNA Movements in <italic>Escherichia coli</italic>.
Article in Microbial physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The bacterial SOS response promotes the expression of the transposase encoded by ISJournal of bacteriology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionThe transposase protein, InsAB', is the key cytoplastic determinant that catalyzes IS1 movement within a single DNA molecule or between two DNA molecules. Regulation of InsAB' synthesis, its structural characteristics, and its potent cis effect on IS1 transposition have been subjects of thorough investigation. However, limited efforts have been devoted to measuring the levels of IS1 transcripts and transposases made by native IS1 elements and examining their trans-acting function, particularly concerning their role in transposing otherwise immobile IS1 elements and other target DNA segments within the bacterial genome.
methodsAll constructs were made on the Escherichia coli chromosome using the lambda-Red system. IS1 transposition frequencies were determined using Bgl+ mutation assays, colony PCR and DNA sequencing. IS1 transcripts and transposases were quantitated using lacZ transcriptional and translational reporters.
resultsWe first confirm that a native IS1 element, IS1E, can transpose at a dramatically elevated rate in the absence of both transcriptional and post-transcriptional regulations. Using lacZ reporters targeting the transposase gene insAB', we reveal that the InsA repressor moderately reduces insAB' transcription by as much as 16.8-fold. However, the combined action of InsA and ribosomal frameshifting leads to a much stronger reduction in InsAB' production, by up to 735-fold. We show that only a small percentage (roughly 1.6%) of IS1 transcripts are successfully translated into InsAB', highlighting the primary role of post-transcriptional regulation over transcriptional repression in governing IS1 transposition. We also demonstrate, for the first time, that high levels of InsAB' exhibit a strong trans effect, being capable of efficiently transposing not only normally non-mobile IS1 elements but also a larger miniIS1 cassette within the genome, with greater amounts of InsAB' leading to higher frequencies of transposition.
conclusionsBy dissecting and quantitating the roles of transcriptional and translational controls in transposase production, our study reveals that post-transcriptional regulation via ribosomal frameshifting is the central mechanism governing IS1 intragenomic transposition. Our findings demonstrate that IS1 transposases function in trans, mediating the movement of DNA segments specifically bordered by its inverted repeat at the left end and right end sequences. These findings advance our comprehension of how IS elements mobilize within bacterial genomes and provide potential strategies to counter IS1-mediated antibiotic resistance in clinical bacterial isolates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.